Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Stuttgart - Delayed Quote EUR

Dr Reddy's Laboratories Ltd (RDDA.SG)

12.40

-0.10

(-0.80%)

At close: February 27 at 3:58:19 PM GMT+1

Key Events

Loading Chart for RDDA.SG

9/21 12:03 PM

DELL

Previous Close 12.50
Open 12.20
Bid 12.30 x 111100
Ask 12.50 x 111100
Day's Range 12.20 - 12.40
52 Week Range 12.20 - 15.40
Volume 0
Avg. Volume 344
Market Cap (intraday) --
Beta (5Y Monthly) --
PE Ratio (TTM) --
EPS (TTM) --
Earnings Date Jan 23, 2025
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Trailing total returns as of 2/28/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

RDDA.SG

16.78%

S&P BSE SENSEX

5.58%

1-Year Return

RDDA.SG

11.05%

S&P BSE SENSEX

2.04%

3-Year Return

RDDA.SG

52.36%

S&P BSE SENSEX

31.17%

5-Year Return

RDDA.SG

113.50%

S&P BSE SENSEX

92.66%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Dr Reddy's Laboratories Ltd

12.40

-0.80%

Mkt Cap EUR -

Industry Drug Manufacturers—Specialty & Generic

Syntara Limited

0.0800

-3.61%

Mkt Cap AUD 129.866M

Industry Drug Manufacturers—Specialty & Generic

ANI Pharmaceuticals, Inc.

54.58

-0.78%

Mkt Cap 1.147B

Industry Drug Manufacturers—Specialty & Generic

Amphastar Pharmaceuticals, Inc.

31.49

+0.90%

Mkt Cap 1.514B

Industry Drug Manufacturers—Specialty & Generic

11.46

-2.63%

Mkt Cap 3.46B

Industry Drug Manufacturers—Specialty & Generic

9.53

-15.21%

Mkt Cap 11.375B

Industry Drug Manufacturers—Specialty & Generic

Teva Pharmaceutical Industries Limited

16.32

-2.74%

Mkt Cap 19.208B

Industry Drug Manufacturers—Specialty & Generic

Valuation Measures

    Annual 

As of 2/26/2025

Market Cap

10.24B
Enterprise Value

10.16B
Trailing P/E

17.80
Forward P/E

15.36
PEG Ratio (5yr expected)

4.44
Price/Sales (ttm)

3.07
Price/Book (mrq)

3.00
Enterprise Value/Revenue

2.99
Enterprise Value/EBITDA

10.14

Financial Highlights

Profitability and Income Statement

Profit Margin

--
Return on Assets (ttm)

--
Return on Equity (ttm)

--
Revenue (ttm)

--
Net Income Avi to Common (ttm)

--
Diluted EPS (ttm)

--

Balance Sheet and Cash Flow

Total Cash (mrq)

--
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

--

RDDA.DU Dr Reddy's Laboratories Ltd

12.30

0.00%

RDDA.BE Dr Reddy's Laboratories Ltd

12.10

-1.63%

RDDA.MU Dr Reddy's Laboratories Ltd

12.50

-1.57%

RDDA.F Dr. Reddy's Laboratories Limited

12.30

0.00%

DRREDDY.BO Dr. Reddy's Laboratories Limited

1,113.40

-1.11%

DRREDDY.NS Dr. Reddy's Laboratories Limited

1,117.70

-0.70%